Found: 60
Select item for more details and to access through your institution.
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 4, p. 513, doi. 10.3390/pharmaceutics16040513
- By:
- Publication type:
- Article
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 3, p. 392, doi. 10.3390/pharmaceutics16030392
- By:
- Publication type:
- Article
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, p. 1, doi. 10.1186/s41181-024-00242-6
- By:
- Publication type:
- Article
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [ 111 In]In-Radioligands: Synthesis and Preclinical Profile.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1921, doi. 10.3390/ijms25031921
- By:
- Publication type:
- Article
Side-Chain Modified [ 99m Tc]Tc-DT1 Mimics: A Comparative Study in NTS 1 R-Positive Models.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15541, doi. 10.3390/ijms242115541
- By:
- Publication type:
- Article
Toward Stability Enhancement of NTS 1 R-Targeted Radioligands: Structural Interventions on [ 99m Tc]Tc-DT1.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2092, doi. 10.3390/pharmaceutics15082092
- By:
- Publication type:
- Article
Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1134, doi. 10.3390/biom13071134
- By:
- Publication type:
- Article
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 5, p. 674, doi. 10.3390/ph16050674
- By:
- Publication type:
- Article
[ 111 In]In/[ 177 Lu]Lu-AAZTA 5 -LM4 SST 2 R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 776, doi. 10.3390/pharmaceutics15030776
- By:
- Publication type:
- Article
[<sup>111</sup>In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 3, p. 892, doi. 10.1007/s00259-022-05992-6
- By:
- Publication type:
- Article
[ 68 Ga]Ga-DATA 5m -LM4, a PET Radiotracer in the Diagnosis of SST 2 R-Positive Tumors: Preclinical and First Clinical Results.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14590, doi. 10.3390/ijms232314590
- By:
- Publication type:
- Article
Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK 2 R Cancer Theranostic Agents: A Preclinical Study.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 3, p. 666, doi. 10.3390/pharmaceutics14030666
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
Radiolabeled Bombesin Analogs.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5766, doi. 10.3390/cancers13225766
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
[ 99m Tc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5093, doi. 10.3390/cancers13205093
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
In memoriam: Marion Hendriks-de Jong.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [ 99m Tc]Tc-DB4 and [ 111 In]In-SG4 in Mice Treated with Entresto.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 12, p. 1145, doi. 10.3390/pharmaceutics12121145
- By:
- Publication type:
- Article
Imaging of inflammatory cellular protagonists in human atherosclerosis: a dual-isotope SPECT approach.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 12, p. 2856, doi. 10.1007/s00259-020-04776-0
- By:
- Publication type:
- Article
Optimizing the Profile of [ 99m Tc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 7926, doi. 10.3390/ijms21217926
- By:
- Publication type:
- Article
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.
- Published in:
- Molecules, 2020, v. 25, n. 15, p. 3418, doi. 10.3390/molecules25153418
- By:
- Publication type:
- Article
Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 6, p. 528, doi. 10.3390/pharmaceutics12060528
- By:
- Publication type:
- Article
Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist <sup>177</sup>Lu‐DOTAGA‐PEG<sub>2</sub>‐RM26.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3347, doi. 10.1002/ijc.32401
- By:
- Publication type:
- Article
Theranostic approaches in nuclear oncology: From bench to bed.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 612, doi. 10.1002/jlcr.3787
- By:
- Publication type:
- Article
Comparative evaluation of the new GRPR‐antagonist <sup>111</sup>In‐SB9 and <sup>111</sup>In‐AMBA in prostate cancer models: Implications of in vivo stability.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 646, doi. 10.1002/jlcr.3733
- By:
- Publication type:
- Article
Instant kit preparation of <sup>68</sup>Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [<sup>68</sup>Ga]Ga-DATA-TOC.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0516-7
- By:
- Publication type:
- Article
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair.
- Published in:
- Molecules, 2019, v. 24, n. 6, p. 1015, doi. 10.3390/molecules24061015
- By:
- Publication type:
- Article
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses.
- Published in:
- Pharmaceuticals (14248247), 2019, v. 12, n. 1, p. 42, doi. 10.3390/ph12010042
- By:
- Publication type:
- Article
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A novel CCK<sub>2</sub>/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study.
- Published in:
- Polish Archives of Internal Medicine, 2018, v. 128, n. 12, p. 791, doi. 10.20452/pamw.4387
- By:
- Publication type:
- Article
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [<sup>67</sup>Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.
- Published in:
- Molecules, 2017, v. 22, n. 11, p. 1950, doi. 10.3390/molecules22111950
- By:
- Publication type:
- Article
<sup>68</sup>Ga/<sup>177</sup>Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 2, p. 293, doi. 10.2967/jnumed.116.176636
- By:
- Publication type:
- Article
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 75, doi. 10.2967/jnumed.116.178889
- By:
- Publication type:
- Article
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [Ga]SB3 and PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 5, p. 964, doi. 10.1007/s00259-015-3232-1
- By:
- Publication type:
- Article
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [In-DOTA]MG11-first estimates for clinical translation.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-015-0158-3
- By:
- Publication type:
- Article
In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 5, p. 752, doi. 10.2967/jnumed.114.153023
- By:
- Publication type:
- Article
GRP Receptor Imaging of Prostate Cancer Using [Tc]Demobesin 4: a First-in-Man Study.
- Published in:
- Molecular Imaging & Biology, 2014, v. 16, n. 6, p. 888, doi. 10.1007/s11307-014-0754-z
- By:
- Publication type:
- Article
GRP receptor imaging of prostate cancer using [(99m)Tc]Demobesin 4: a first-in-man study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
"To Serve and Protect": Enzyme Inhibitors as Radiopeptide Escorts Promote Tumor Targeting.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 1, p. 121, doi. 10.2967/jnumed.113.129411
- By:
- Publication type:
- Article
<sup>99m</sup>Tc Radiotracers Based on Human GRP(18-27): Synthesis and Comparative Evaluation.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 10, p. 1797, doi. 10.2967/jnumed.112.118695
- By:
- Publication type:
- Article
[In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study.
- Published in:
- EJNMMI Research, 2012, v. 2, n. 1, p. 1, doi. 10.1186/2191-219X-2-25
- By:
- Publication type:
- Article
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 8, p. 1426, doi. 10.1007/s00259-011-1818-9
- By:
- Publication type:
- Article
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1265, doi. 10.1007/s00259-009-1098-9
- By:
- Publication type:
- Article
Synthesis and sst<sub>2</sub> binding profiles of new [Tyr<sup>3</sup>]octreotate analogs.
- Published in:
- Journal of Peptide Science, 2008, v. 14, n. 6, p. 725, doi. 10.1002/psc.989
- By:
- Publication type:
- Article
Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 2, p. 318, doi. 10.2967/jnumed.107.045054
- By:
- Publication type:
- Article